The role of ubiquitin-proteasome system in glioma survival and growth

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Growth Factors

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08977194.2013.799156PMID 23688106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth

  2013cited by this paper
• c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.

  2013cited by this paper
• Small ubiquitin‐like modifier 1–3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival

  2013cited by this paper
• Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.

  2012cited by this paper
• Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma

  2012cited by this paper
• USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

  2012cited by this paper
• Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets

  2012cited by this paper
• The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases

  2012influential reference
• microRNA-214-mediated UBC9 expression in glioma

  2012cited by this paper
• Increased Expression of FAT10 is Correlated with Progression and Prognosis of Human Glioma

  2012cited by this paper
• PTBP1‐dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis

  2012cited by this paper
• Structure and function of the ubiquitin-proteasome system: modulation of components.

  2012cited by this paper
• Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.

  2012cited by this paper
• Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.

  2012cited by this paper
• Numb Regulates Glioma Stem Cell Fate and Growth by Altering Epidermal Growth Factor Receptor and Skp1‐Cullin‐F‐Box Ubiquitin Ligase Activity

  2012cited by this paper
• UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro.

  2012cited by this paper
• A Novel Gene RNF138 Expressed in Human Gliomas and Its Function in the Glioma Cell Line U251

  2011cited by this paper
• Mislocalization of the E3 Ligase, β-Transducin Repeat-containing Protein 1 (β-TrCP1), in Glioblastoma Uncouples Negative Feedback between the Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase 1 (PHLPP1) and Akt*

  2011influential reference
• Carboxyl terminus of Hsp70‐interacting protein (CHIP) contributes to human glioma oncogenesis

  2011cited by this paper
• HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 Degradation*

  2011cited by this paper
• FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.

  2010cited by this paper
• Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening

  2009cited by this paper
• Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin–proteasome pathway

  2009cited by this paper
• EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor

  2009cited by this paper
• β-TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt

  2009cited by this paper
• Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

  2009cited by this paper
• A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers

  2009cited by this paper
• Squelching glioblastoma stem cells by targeting REST for proteasomal degradation.

  2009cited by this paper
• Tumour suppressors: Different roads to inactivation

  2009cited by this paper
• Transforming growth factor-β signaling and ubiquitinators in cancer

  2008cited by this paper
• LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII

  2008cited by this paper
• Special Topic: NF-κB, Immunity and Cancer NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

  2008cited by this paper
• FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway.

  2008cited by this paper
• Epidermal Growth Factor Receptor vIII Expression in U87 Glioblastoma Cells Alters Their Proteasome Composition, Function, and Response to Irradiation

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.

  2008cited by this paper
• Ubiquitin-proteasome system as a modulator of cell fate.

  2008influential reference
• Nuclear Factor-κB: Fine-Tuning a Central Integrator of Diverse Biologic Stimuli

  2008cited by this paper
• Identification of survival‐related genes of the phosphatidylinositol 3′‐kinase signaling pathway in glioblastoma multiforme

  2008cited by this paper
• NF-kappaB controls growth of glioblastomas/astrocytomas.

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Mdm2 exerts pro-apoptotic activities by antagonizing insulin-like growth factor-I-mediated survival

  2008cited by this paper
• Insulin-like growth factor type I biology and targeting in malignant gliomas.

  2007cited by this paper
• Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis.

  2007cited by this paper
• TGFbeta signalling in control of T-cell-mediated self-reactivity.

  2007cited by this paper
• NF-κB controls growth of glioblastomas/astrocytomas

  2007cited by this paper
• The Gli code: an information nexus regulating cell fate, stemness and cancer.

  2007cited by this paper
• PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

  2007cited by this paper
• Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell Growth In vivo

  2007cited by this paper
• Malignant glioma: Neuropathology and Neurobiology

  2006cited by this paper
• Signals from within: the DNA-damage-induced NF-κB response

  2006cited by this paper
• Conjugation to Nedd8 Instigates Ubiquitylation and Down-regulation of Activated Receptor Tyrosine Kinases*

  2006cited by this paper
• FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

  2006cited by this paper
• Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination

  2006cited by this paper
• Signals from within: the DNA-damage-induced NF-kappaB response.

  2006cited by this paper
• Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.

  2006cited by this paper
• Ubiquitin and ubiquitin-like proteins in cancer pathogenesis

  2006cited by this paper
• Ubiquitin and NEDD8: Brothers in Arms

  2006cited by this paper
• High levels of Notch signaling down-regulate Numb and Numblike

  2006cited by this paper
• Alix Facilitates the Interaction between c-Cbl and Platelet-derived Growth Factor β-Receptor and Thereby Modulates Receptor Down-regulation*

  2006cited by this paper
• The ubiquitin-proteasome pathway and its role in cancer.

  2005cited by this paper
• Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase.

  2005cited by this paper
• Murine FGF-Inducible Kinase is Rapidly Degraded via the Nuclear Ubiquitin-Proteosome System When Overexpressed in NIH 3T3 Cells

  2004cited by this paper
• LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation

  2004cited by this paper
• The ubiquitin‐proteasome pathway

  2004cited by this paper
• [Targeting of membrane receptor tyrosine kinases: is there resistance in the HER?].

  2004cited by this paper
• NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival

  2004cited by this paper
• The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended.

  2004influential reference
• Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.

  2004cited by this paper
• Ciblage des récepteurs tyrosine kinase membranaires : y a-t-il de la résistance dans l’HER ?

  2004cited by this paper
• NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival.

  2004cited by this paper
• The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.

  2004cited by this paper
• Functions of NF-?B1 and NF-?B2 in immune cell biology

  2004cited by this paper
• The proteasome: structure, function, and role in the cell.

  2003cited by this paper
• Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization

  2003cited by this paper
• On and off: proteasome and TGF-beta signaling.

  2003cited by this paper
• Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.

  2003cited by this paper
• Protein Kinase C Controls Microtubule-based Traffic but Not Proteasomal Degradation of c-Met*

  2003cited by this paper
• Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells

  2003cited by this paper
• Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells.

  2003cited by this paper
• On and off: proteasome and TGF-β signaling

  2003cited by this paper
• Hedgehog–GLI signaling and the growth of the brain

  2002cited by this paper
• Scatter Factor/Hepatocyte Growth Factor Stimulation of Glioblastoma Cell Cycle Progression through G1 Is c-Myc Dependent and Independent of p27 Suppression, Cdk2 Activation, or E2F1-Dependent Transcription

  2002cited by this paper
• Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma.

  2002cited by this paper
• Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape

  2001cited by this paper
• Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

  2001cited by this paper
• Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas.

  2001cited by this paper
• Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.

  2001cited by this paper
• The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis.

  2001cited by this paper
• Ubiquitin‐mediated proteolysis: biological regulation via destruction

  2000cited by this paper
• The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB).

  2000cited by this paper
• Cell Adhesion Regulates Ubiquitin-mediated Degradation of the Platelet-derived Growth Factor Receptor β*

  2000cited by this paper
• Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).

  2000cited by this paper
• NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition

  1999cited by this paper
• Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis

  1999cited by this paper
• Ligand-induced Ubiquitination of the Epidermal Growth Factor Receptor Involves the Interaction of the c-Cbl RING Finger and UbcH7*

  1999cited by this paper
• SMAD destruction turns off signalling

  1999cited by this paper
• Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.

  1999cited by this paper
• Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells.

  1999cited by this paper
• Inhibition of Nuclear Factor-κB Activation Confers Sensitivity to Tumor Necrosis Factor-α by Impairment of Cell Cycle Progression in Human Glioma Cells

  1999cited by this paper

• Targeting VCP with V8 suppresses glioblastoma development via formation of aggregates and disruption of mitophagy flux

  2026cites this paper
• Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms

  2022cites this paper
• Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities

  2022cites this paper
• Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin

  2022cites this paper
• Proteasome inhibition—a new target for brain tumours

  2019cites this paper
• A prognostic signature based on three non‐coding RNAs for prediction of the overall survival of glioma patients

  2019cites this paper
• Mécanismes moléculaires impliqués dans la plasticité neurovasculaire des cellules souches de glioblastome

  2016cites this paper
• Protein species as diagnostic markers.

  2016cites this paper
• Altering protein degradation via the ubiquitin proteasomal system or autophagy, and its impact on tau degradation and aggregation

  2014cites this paper
• Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma

  2014cites this paper
• Clinical Implications of Girdin Protein Expression in Glioma

  2013cites this paper